首页> 外文OA文献 >Intracerebroventricular gene therapy that delays neurological disease progression is associated with selective preservation of retinal ganglion cells in a canine model of CLN2 disease

【2h】

Intracerebroventricular gene therapy that delays neurological disease progression is associated with selective preservation of retinal ganglion cells in a canine model of CLN2 disease

机译：延迟神经系统疾病进展的脑室内基因治疗与在CLN2疾病的犬模型中选择性保存视网膜神经节细胞有关

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Whiting Rebecca E.H.; Jensen Cheryl A.; Pearce Jacqueline W.; Gillespie Lauren E.; Bristow Daniel E.; Katz Martin L.;
展开▼
作者单位

展开▼
年度 2016
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Intracerebroventricular gene therapy that delays neurological disease progression is associated with selective preservation of retinal ganglion cells in a canine model of CLN2 disease [J] . Whiting Rebecca E. H., Jensen Cheryl A., Pearce Jacqueline W., Experimental Eye Research . 2016,第Null期

机译：延迟神经系统疾病进展的脑室内基因治疗与在CLN2疾病的犬模型中选择性保存视网膜神经节细胞有关
2. Extraneuronal pathology in a canine model of CLN2 neuronal ceroid lipofuscinosis after intracerebroventricular gene therapy that delays neurological disease progression [J] . Katz M. L., Johnson G. C., Leach S. B., Gene therapy . 2017,第4期

机译：在脑内基因治疗后Cln2神经元曲线痘痘患者犬模型中的肝癌模型延迟神经疾病进展
3. Intravitreal Enzyme replacement therapy attenuates retinal disease progression in a canine model of neuronal ceroid lipofuscinosis type 2 (CLN2) [J] . Sinclair John, Whiting Rebecca, Robinson Grace, Investigative ophthalmology & visual science . 2018,第9期

机译：玻璃体内酶替代治疗衰减神经元曲线痘痘型患者犬模型中的视网膜疾病进展（CLN2）
4. SELECTIVE RENAL INTRA-ARTERIAL (IA) AND NON-SELECTIVE INTRAVENOUS (IV) DELIVERY OF AUTOLOGOUS MESENCHYMAL-DERIVED STEM CELLS (MSC) IN CANINE AND FELINE PATIENTS WITHACUTE AND CHRONIC KIDNEY DISEASE [C] . Allyson Berent Conference of the American College of Veterinary Internal Medicine . 2013

机译：在犬和哺乳动物患者中，在犬和哺乳动物患者中，选择性肾内动脉（IA）和非选择性静脉内（IV）递送自体间充质衍生的干细胞（MSC）
5. Systemic AAV-mediated gene therapy using Epo-R76E to protect retinal ganglion cells from optic nerve injury and disease [D] . Sullivan, Timothy A. 2011

机译：使用Epo-R76E的系统性AAV介导的基因疗法可保护视网膜神经节细胞免于视神经损伤和疾病
6. Intracerebroventricular gene therapy that delays neurological disease progression is associated with selective preservation of retinal ganglion cells in a canine model of CLN2 disease [O] . Rebecca E.H. Whiting, Cheryl A. Jensen, Jacqueline W. Pearce, -1

机译：延迟神经系统疾病进展的脑室内基因治疗与CLN2病犬模型中视网膜神经节细胞的选择性保存有关
7. Preservation of vision following cell-based therapies in a model of retinal degenerative disease [O] . McGill T.J., Lund R.D., Douglas R.M., 2004

机译：视网膜变性疾病模型中基于细胞的治疗后的视力保护

Intracerebroventricular gene therapy that delays neurological disease progression is associated with selective preservation of retinal ganglion cells in a canine model of CLN2 disease

著录项

引文网络

相似文献

相关主题

期刊订阅